Gen9
Cambridge, Massachusetts, United States
About Gen9
Gen9 is building on advances in synthetic biology to power a scalable fabrication capability that will significantly increase the world’s capacity to produce DNA content. The privately held company’s next-generation gene synthesis technology allows for the high-throughput, automated production of DNA constructs at lower cost and higher accuracy than previous methods on the market. Founded by world leaders in synthetic biology, Gen9 aims to ensure the constructive application of synthetic biology in industries ranging from enzyme and chemical production to pharmaceuticals and biofuels. Gen9 was established in 2009 and is based in Cambridge, Massachusetts, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $50.1M
- Funding stage: M&A
- Last round: Series Unknown (Jul 2014)
- Website: gen9bio.com
- Phone: 8154258745
Industries & Categories
Biotechnology, Genetics, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/gen9-2605258 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.